These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9127394)
1. Hemodynamic effects and clinical determinants of defibrillation threshold for transvenous atrial defibrillation using biatrial biphasic shocks in patients with chronic atrial fibrillation. Lok NS; Lau CP; Ho DS; Tang YW Pacing Clin Electrophysiol; 1997 Apr; 20(4 Pt 1):899-908. PubMed ID: 9127394 [TBL] [Abstract][Full Text] [Related]
2. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. Lok NS; Lau CP; Tse HF; Ayers GM J Am Coll Cardiol; 1997 Nov; 30(5):1324-30. PubMed ID: 9350935 [TBL] [Abstract][Full Text] [Related]
3. A comparison of transvenous atrial defibrillation of acute and chronic atrial fibrillation and the effect of intravenous sotalol on human atrial defibrillation threshold. Lau CP; Lok NS Pacing Clin Electrophysiol; 1997 Oct; 20(10 Pt 1):2442-52. PubMed ID: 9358486 [TBL] [Abstract][Full Text] [Related]
4. Multicenter low energy transvenous atrial defibrillation (XAD) trial results in different subsets of atrial fibrillation. Lévy S; Ricard P; Lau CP; Lok NS; Camm AJ; Murgatroyd FD; Jordaens LJ; Kappenberger LJ; Brugada P; Ripley KL J Am Coll Cardiol; 1997 Mar; 29(4):750-5. PubMed ID: 9091520 [TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations. Saksena S; Prakash A; Mangeon L; Varanasi S; Kolettis T; Mathew P; De Groot P; Mehra R; Krol RB Am J Cardiol; 1995 Nov; 76(12):913-21. PubMed ID: 7484831 [TBL] [Abstract][Full Text] [Related]
6. Internal cardioversion of atrial fibrillation in sheep. Cooper RA; Alferness CA; Smith WM; Ideker RE Circulation; 1993 May; 87(5):1673-86. PubMed ID: 8491023 [TBL] [Abstract][Full Text] [Related]
7. Ventricular proarrhythmic effects of ventricular cycle length and shock strength in a sheep model of transvenous atrial defibrillation. Ayers GM; Alferness CA; Ilina M; Wagner DO; Sirokman WA; Adams JM; Griffin JC Circulation; 1994 Jan; 89(1):413-22. PubMed ID: 8281677 [TBL] [Abstract][Full Text] [Related]
8. Transvenous internal cardioversion for atrial fibrillation: a randomized study on defibrillation threshold and tolerability of asymmetrical compared with symmetrical shocks. Boriani G; Biffi M; Zannoli R; Branzi A; Magnani B Int J Cardiol; 1999 Sep; 71(1):63-9. PubMed ID: 10522566 [TBL] [Abstract][Full Text] [Related]
9. Multistage electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation with lower energy than a single biphasic shock. Janardhan AH; Gutbrod SR; Li W; Lang D; Schuessler RB; Efimov IR J Am Coll Cardiol; 2014 Jan 7-14; 63(1):40-8. PubMed ID: 24076284 [TBL] [Abstract][Full Text] [Related]
10. Safety of transvenous low energy cardioversion of atrial fibrillation in patients with a history of ventricular tachycardia: effects of rate and repolarization time on proarrhythmic risk. Simons GR; Newby KH; Kearney MM; Brandon MJ; Natale A Pacing Clin Electrophysiol; 1998 Feb; 21(2):430-7. PubMed ID: 9507545 [TBL] [Abstract][Full Text] [Related]
11. Initial clinical experience with an implantable human atrial defibrillator. Lau CP; Tse HF; Lok NS; Lee KL; Ho DS; Sopher M; Murgatroyd F; Camm AJ Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 2):220-5. PubMed ID: 9121994 [TBL] [Abstract][Full Text] [Related]
13. Transvenous single lead atrial defibrillation: efficacy and risk of ventricular fibrillation in an ischemic canine model. Osswald S; Trouton TG; Roelke M; O'Nunain SS; Fallon JT; Holden HB; Ruskin JN; Garan H Pacing Clin Electrophysiol; 1998 Mar; 21(3):580-9. PubMed ID: 9558691 [TBL] [Abstract][Full Text] [Related]
14. [Atrial defibrillator]. Jung W; Lüderitz B Z Kardiol; 2000; 89 Suppl 3():206-14. PubMed ID: 10810804 [TBL] [Abstract][Full Text] [Related]
15. Low-energy transvenous cardioversion of atrial fibrillation using a single atrial lead system. Heisel A; Jung J; Neuzner J; Michel U; Pitschner H J Cardiovasc Electrophysiol; 1997 Jun; 8(6):607-14. PubMed ID: 9209961 [TBL] [Abstract][Full Text] [Related]
16. Spontaneous reinitiation of atrial fibrillation following transvenous atrial defibrillation. Sra J; Biehl M; Blanck Z; Dhala A; Jazayeri MR; Deshpande S; Akhtar M Pacing Clin Electrophysiol; 1998 May; 21(5):1105-10. PubMed ID: 9604243 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of transvenous atrial cardioversion in patients with mitral valve disease and long-standing atrial fibrillation. Grönefeld GC; Li YG; Bogun F; Hohnloser SH Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):1894-7. PubMed ID: 11139952 [TBL] [Abstract][Full Text] [Related]
18. Atrial fibrillation induction and determination of atrial vulnerable period using very low energy synchronized biatrial shock in normal subjects and in patients with atrial fibrillation. Tse HF; Lau CP; Ayers GM Pacing Clin Electrophysiol; 2000 Apr; 23(4 Pt 1):469-76. PubMed ID: 10793436 [TBL] [Abstract][Full Text] [Related]
19. Low-energy cardioversion of spontaneous atrial fibrillation. Immediate and long-term results. Lévy S; Ricard P; Gueunoun M; Yapo F; Trigano J; Mansouri C; Paganelli F Circulation; 1997 Jul; 96(1):253-9. PubMed ID: 9236442 [TBL] [Abstract][Full Text] [Related]